NCT02864615View on ClinicalTrials.gov

Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2018

Study Completion Date

August 31, 2018

Conditions
Metastatic Renal Cell Carcinoma
Interventions
RADIATION

SBRT

Dose and schedule will be depended on metastases location.

Trial Locations (1)

Unknown

Ulyanovsk regional cancer center, Ulyanovsk

All Listed Sponsors
lead

Kidney Cancer Research Bureau

OTHER

NCT02864615 - Safety and Preliminary Efficacy of SBRT in Patients With Metastatic RCC Treated With Targeted or IO Therapy | Biotech Hunter | Biotech Hunter